Evaluating the renoprotective effectiveness of sodium-glucose co-transporter 2 inhibitor therapy in patients with chronic kidney disease: A prospective study

Evaluating the renoprotective effectiveness of sodium-glucose co-transporter 2 inhibitor therapy in patients with chronic kidney disease: A prospective study

Background/Aim. Chronic kidney disease (CKD) is a global health concern associated with increased cardio-vascular risks and premature mortality. Proteinuria is a key prognostic indicator for CKD outcome. Sodium-glucose cotransporter 2 (SGLT2) inhibitors show potential for reducing proteinuria and sl...

Full description

Bibliographic Details
Main Authors:	Karadžić-Ristanović Vidna, Gajić Selena, Bontić Ana, Pavlović Jelena, Kezić Aleksandra, Radovanović Jovana, Radović Milan
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2024-01-01
Series:	Vojnosanitetski Pregled
Subjects:	drug therapy proteinuria renal insufficiency, chronic sodium-glucose transporter 2 inhibitors treatment outcome
Online Access:	https://doiserbia.nb.rs/img/doi/0042-8450/2024/0042-84502300061K.pdf

Similar Items

Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
by: Nam Hoon Kim, et al.
Published: (2022-07-01)

Emerging Role of Sodium–Glucose Co-Transporter 2 Inhibitors for the Treatment of Chronic Kidney Disease
by: Isidto R, et al.
Published: (2023-02-01)

Sodium Intake and Proteinuria/Albuminuria in the Population—Observational, Cross-Sectional Study
by: Massimo Cirillo, et al.
Published: (2021-04-01)

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
by: Tomoaki Takata, et al.
Published: (2021-04-01)

Mechanisms of renoprotective action of sodium-glucose cotransporter-2 inhibitors (gliflozins): a clinician’s view
by: Ya.M. Lutai, et al.
Published: (2023-03-01)

Increased Peritoneal Protein Loss and Diabetes: Is There a Link?
by: Ana Bontić, et al.
Published: (2023-04-01)

Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
by: Resham Raj Poudel
Published: (2013-01-01)

Sodium–glucose cotransporters: Functional properties and pharmaceutical potential
by: Ryuhei Sano, et al.
Published: (2020-07-01)

World kidney day 2011: protect your kidneys, save your heart
by: William G Couser, et al.
Published: (2010-01-01)

Chronic kidney disease prevention campaign: relationship between proteinuria and elderly people
by: Júlio César Chaves Nunes Filho, et al.
Published: (2022-11-01)

Justification of the renoprotective action of the mixture of sodium chloride and sodium bicarbonate solutions in phenylhydrazine intoxication
by: V. Sirman, et al.
Published: (2023-09-01)

Renoprotective effect of additional sodium–glucose cotransporter 2 inhibitor therapy in type 2 diabetes patients with rapid decline and preserved renal function
by: Kentaro Sada, et al.
Published: (2022-08-01)

Research advances on renoprotective mechanism of SGLT-2 inhibitors in non-diabetic kidney disease
by: Feng Liu, et al.
Published: (2023-10-01)

Current Use and Complementary Value of Combining in Vivo Imaging Modalities to Understand the Renoprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors at a Tissue Level
by: Sjoukje van der Hoek, et al.
Published: (2022-02-01)

Renoprotective effects of teneligliptin: An observational study
by: Prabhat Agrawal, et al.
Published: (2021-01-01)

Albumin-to-protein ratio in spot urine samples for analysis of proteinuria selectivity in chronic kidney disease
by: Miguel Augusto Martins Pereira, et al.
Published: (2022-10-01)

Proteinuria persistente en pacientes pediátricos, caracterización histopatológica y su influencia en la progresión de la enfermedad renal crónica
by: Juliana Castillo Orozco, et al.
Published: (2018-01-01)

Past Sodium Intake, Contemporary Sodium Intake, and Cardiometabolic Health in Southwest Coastal Bangladesh
by: Abu Mohd Naser, et al.
Published: (2020-09-01)

The Influence of Different Levels of Sodium Chloride, Sodium Nitrite, and Glucose on Biogenic Amines and Microbial Communities in Fermented Goat Meat Sausage
by: Shuanghui Wu, et al.
Published: (2024-03-01)

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes
by: Koki Chiba, et al.
Published: (2021-02-01)

Influence of starch and casein administered postruminally on small intestinal sodium-glucose cotransport activity and expression
by: Kátia Cylene Guimaraes, et al.
Published: (2007-11-01)

SGLT-2 Inhibitors and Renal Outcomes in Non-Diabetic Patients: A Systematic Review
by: Mariana Silva de Sousa, et al.
Published: (2023-06-01)

Current developments in peritoneal glucose transport and sodium-glucose co-transporter 2 inhibitors during peritoneal dialysis
by: Fan Yang, et al.
Published: (2023-11-01)

The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits
by: Kozlowski P, et al.
Published: (2017-03-01)

Glucose and Sodium Levels as Disease Outcome Predictors in Critically Ill Patients
by: Željka Dragila, et al.
Published: (2023-01-01)

Obesity and chronic kidney disease: prevalence, mechanism, and management
by: Hyung Eun Yim, et al.
Published: (2021-10-01)

Inhibition of α2-adrenoceptor is renoprotective in 5/6 nephrectomy-induced chronic kidney injury rats
by: Kohei Hayashi, et al.
Published: (2021-01-01)

Sodium-glucose co-transporter 2 inhibitors – a review article
by: Marcin Makuch, et al.
Published: (2019-08-01)

Sodium-glucose co-transporter 2 inhibitors – a review article
by: Marcin Makuch, et al.
Published: (2019-08-01)

Sodium-glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients – A Retrospective Single Center Study
by: Joana Freitas, et al.
Published: (2024-01-01)

Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin
by: M. M. Batyushin
Published: (2021-04-01)

Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis
by: Jan P. Kleinjan, et al.
Published: (2024-03-01)

Neurodevelopment of preterm infants with glucose and sodium abnormalities
by: Hui-Ying Yang, et al.
Published: (2021-11-01)

SDS Electrophoresis on Gradient Polyacrylamide Gels as a Semiquantitative Tool for the Evaluation of Proteinuria
by: Paulina Mazur, et al.
Published: (2023-04-01)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
by: Jun Tang, et al.
Published: (2022-02-01)

Severe intoxication caused by sodium-glucose cotransporter 2 inhibitor overdose: a case report
by: Miho Nakamura, et al.
Published: (2020-01-01)

The Renoprotective Effects of Sodium Valproate as a Histone Deacetylase Inhibitor on Diabetic Nephropathy
by: R Ataee, et al.
Published: (2017-09-01)

Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
by: Boyang Xiang, et al.
Published: (2021-04-01)

Pattern, clinical features and response to corticoids of glomerular diseases in a Brazilian population. An analytical cross-sectional study
by: Anaiara Lucena Queiroz, et al.

Acute Glomerulonephritis: A 7 Years Follow up of Children in Center of Iran
by: Mohsen Akhavan Sepahi, et al.
Published: (2011-06-01)